Get started
Author

Oreste Mora

Patient-Reported Outcomes of Patients With Advanced Biliary Tract Cancers Receiving Gemcitabine Plus Capecitabine: A Multicenter, Phase II Trial of the Swiss Group for Clinical Cancer Research
2008 · Dieter Koeberle, Piercarlo Saletti, et al. · Journal of Clinical Oncology · 73
Prognosis of Acute Myeloid Leukemia in the General Population: Data from Southern Switzerland
2009 · Erika Lerch, Vittoria Espeli, et al. · Tumori Journal · 33
A Phase I-II Study to Determine the Maximum Tolerated Infusion Rate of Rituximab with Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function
2008 · Marco Siano, Erika Lerch, et al. · Clinical Cancer Research · 30
Efficacy of alemtuzumab and gemcitabine in a patient with enteropathy‐type T‐cell lymphoma
2008 · Davide Soldini, Oreste Mora, et al. · British Journal of Haematology · 18
A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System
2020 · Ilenia Mascherona, Caterina Maggioli, et al. · Case Reports in Hepatology · 13
PDF
Does the FLIPI apply to grade 3 follicular lymphoma?
2005 · Michele Ghielmini, Oreste Mora · Blood · 10
A Phase I–II Study To Determine the Maximum Tolerated Infusion-Rate of Rituximab, with a Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function.
2007 · Marco Siano, Erika Lerch, et al. · Blood · 3
Severe Dizziness and Hypereosinophilia: Coincidence or Complication? A Case Report
2020 · Giorgia Lo Presti, Beatrice Barda, et al. · Case Reports in Oncology
PDF
Works count: 10
Citation count: 180
H-index: 6
I10-index: 6
Year
Topic
Type